EquiScript reviews about "pto"

First thing you need to know about the sales dept is that it is 100% cold calling. They tell you the leads are warm, but they aren’t. They have no idea who you are or who the company is. If cold calling isn’t for you, then think about looking somewhere else. Second, the new management doesn’t understand what “if it ain’t broke, don’t fix it” means. He wants to leave his legacy behind him in this company on how he made improvements to something that was working well and efficiently to begin with. Changing things that don’t need to be changed. He doesn’t understand our culture or process, he just wants to see an increase in the output of all departments. Overall, there's been a significant declined over the last year and it's not looking like it will improve.

No cons for this company.

The company has had 3 layoffs since December 2020

The company has 2 rounds of massive layoffs. Not due to Covid, but due to financial issues. The way they handled the layoffs was ruthless and out of the blue. They are now making agents who were remote, to come back to the office in the middle of a pandemic and a recession. On top of everything, they constantly are increasing their metrics and they continue to make the commission/ bonus structure more unattainable. The base pay is also way below industry standards

3 layoffs within 4 years of employment. Gone are the days where reps had the ability to generate solid income (80k +). Leadership has a lot of work to do and rethink who they are placing in roles to lead others. Culture has been non-existent last 1 1/2 years. The company is on a downward spiral without any signs of rehabilitation. I hope current and new reps rethink their positioning with Equiscript.

Two lay offs from the time I worked and was let go on that second lay off. Pharmaceutical laws are keeping this company from being successful. Hard to sell a product you don’t trust when customers constantly call in to complain about mistakes or delivery delay. Small tasks are delayed by a week or two not sure now that they may be understaffed. Customers may not be getting the best service out there for mail order if big pharma doesn’t stop monopolizing insurance benefits.

It's cold calling. The constantly changing goals, shifting away from making a sale to making more calls. Very high turn over rate. No growth.

Monotonous work, little room to advance career

Equiscript was originally a great company. Everyone who made the company great has left or has been laid off. I know CEO Michael Burkhold has pure intentions at heart, and I believe he is being misled by others and is steering away from the company’s core values. Due to cuts in the 340B prescription drug program, Equiscript had a mass layoff in 2020. We were ensured that this would prevent anything similar from happening in the near future. This year there was another mass layoff, and the employees that were affected were terminated immediately without any prior warning. They were booted from all systems immediately. There were demotions for the employees who did get to stay. There is so much uncertainty in this company and over time there is less and less transparency in what’s going on in the company. I did believe in this company’s mission, and I do believe that it’s for a good cause, but the company is on a steady decline and the employees have suffered because of the company’s latest and current approach to solving the “issues” at hand. I don’t know the direction Equiscript will go in the near future. But they should start with changing their attitude towards employees. It has gone from great to very poor in a very short amount of time. Equiscript will eventually lose their best employees if they haven’t already. This company will crumble in due time and has completely lost sight of the mission. I believe Michael needs to take back charge and stop letting other people dictate the future of his company. I truly believe that other individuals in leadership are tarnishing the Equiscript name, which Michael has worked so hard to build. It hurts to write this review, seeing where the company was headed to where the company is now going.